Colorectal cancer (CRC) is the third most prevalent cancer in the world. Globally, it has been
estimated that about 1.4 million new cases of colorectal cancer are diagnosed every year …

Colorectal cancer (CRC) develops and progresses through a systematic selection for (epi)
genetic alterations that drive the transformation from normal colon epithelium to …

Objective Highly sensitive guaiac-based faecal occult blood (Hemoccult SENSA) and
Helicobacter pylori stool antigen testing might help detect upper gastrointestinal lesions …

Colorectal cancer (CRC) screening has been shown to be effective in reducing CRC
incidence and mortality. There are currently a number of screening modalities available for …

Colorectal cancer (CRC) is considered to develop slowly via a progressive accumulation of
genetic mutations. Markers of CRC may serve to provide the basis for decision‑making, and …

Despite multiple screening techniques, including colonoscopy, flexible sigmoidoscopy,
radiological imaging, and fecal occult blood testing, colorectal cancer remains a leading …

Colorectal cancer (CRC) is one of the most common life-threatening malignances
worldwide. CRC relapse markedly decreases the 5-year survival of patients following …

Colorectal cancer (CRC) is the most common gastrointestinal malignancy worldwide. The
poor specificity and sensitivity of the fecal occult blood test has prompted the development of …

Colorectal cancer is one of the most common forms of cancer worldwide. Early detection
would allow patients to be treated surgically and halt the progression of the disease; …

Background: To assess the diagnostic potential of tumor-associated high molecular weight
DNA in stool samples of 32 colorectal cancer (CRC) patients compared to 32 healthy …